Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,213,206 papers from all fields of science
Search
Sign In
Create Free Account
Leukemia, Prolymphocytic, B-Cell
Known as:
Leukemia, B-Cell Prolymphocytic
, B-Cell Prolymphocytic Leukemia
, B-Cell Prolymphocytic Leukemias
Expand
A malignant B-cell lymphoproliferative process affecting the blood, bone marrow, and spleen. The B-prolymphocytes are medium-sized, round lymphoid…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Anemia
Atypical lymphocyte
B lymphoblast
B-Lymphocytes
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.
M. Elnenaei
,
D. Jadayel
,
+6 authors
D. Catovsky
Leukemia research : a Forum for Studies on…
2001
Corpus ID: 19336136
2000
2000
p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T‐prolymphocytic leukaemia and Sezary syndrome
V. Brito‐Babapulle
,
R. Hamoudi
,
+4 authors
D. Catovsky
British Journal of Haematology
2000
Corpus ID: 24615488
In a series of 24 patients with chronic T‐lymphoid disorders [13 T‐prolymphocytic leukaemia (T‐PLL) and 11 Sezary syndrome] we…
Expand
Review
1996
Review
1996
Multidrug resistance-associated protein (MRP) in haematological malignancies.
K. Nooter
,
H. Burger
,
G. Stoter
Leukemia and Lymphoma
1996
Corpus ID: 38722142
The presence of multidrug resistant cells, either acquired or de novo, severely limits treatment outcome in haematological…
Expand
Highly Cited
1989
Highly Cited
1989
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases.
M. S. de Oliveira
,
E. Jaffe
,
D. Catovsky
Journal of Clinical Pathology
1989
Corpus ID: 16769577
Sixteen patients presented with B cell leukaemia (white cell count 26-269 x 10(9)/l) which could not be classified as chronic…
Expand
Highly Cited
1989
Highly Cited
1989
Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.
J. Shields
,
R. Armitage
,
B. Jamieson
,
P. Beverley
,
R. Callard
Immunology
1989
Corpus ID: 12232789
Surface IgM (sIgM) was increased up to 10 times on human tonsillar B cells activated with IL-4. No change was observed for…
Expand
1988
1988
Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: a progress report.
T. Han
,
N. Sadamori
,
+4 authors
A. Sandberg
Nouvelle revue francaise d'hematologie
1988
Corpus ID: 43463879
We studied the B lymphocyte metaphases in 78 of 94 cases of CLL, 24 of our 28 hairy cell leukaemias, 4 CLL's which transformed…
Expand
Highly Cited
1986
Highly Cited
1986
The morphological spectrum of T‐prolymphocytic leukaemia
E. Matutes
,
J. Talavera
,
M. O'Brien
,
D. Catovsky
British Journal of Haematology
1986
Corpus ID: 22030549
Summary. The morphology of the cells from 29 cases of T‐prolymphocytic leukaemia (T‐PLL) was studied by light (LM) and…
Expand
1986
1986
Prolymphocytoid transformation of CLL: a clinical and immunological study of 22 cases.
A. Stark
,
H. Limbert
,
B. Roberts
,
R. Jones
,
C. S. Scott
Leukemia research : a Forum for Studies on…
1986
Corpus ID: 35535602
1981
1981
Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes.
K. Ganeshaguru
,
N. Lee
,
+6 authors
M. Greaves
Leukemia research : a Forum for Studies on…
1981
Corpus ID: 10295338
1980
1980
The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia
I. Lampert
,
D. Catovsky
,
G. Marsh
,
J. Child
,
D. Galton
Histopathology
1980
Corpus ID: 25912042
The histological features of prolymphocytic leukaemia are described in spleen, lymph nodes, liver and bone marrow from nine cases…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE